Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
针对动物微生物共生体中的耐多药病原体的新型抗菌药物
基本信息
- 批准号:10592380
- 负责人:
- 金额:$ 595.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnabolismAnimalsAnti-Infective AgentsAntibioticsAntimicrobial ResistanceBacteriaBiologicalBiological AssayChemicalsComputational BiologyCulture TechniquesDevelopmentDrug resistanceEcologyEnvironmentEpidemicGenomicsGoalsHealthHumanIn VitroInvertebratesInvestigationLeadLibrariesMedicineMethodsMicrobeMicrobial Genome SequencingMiningMinorityNatural CompoundNatural ProductsNatural Products ChemistryPathogenesisPathway interactionsPharmaceutical PreparationsProductionPropertyPublic HealthResearchResistanceResourcesSafetySeriesSoilSourceStreptomycesSymbiosisTaxonTechniquesTechnologyTestingTherapeuticWisconsinWorkantimicrobialantimicrobial drugantimicrobial resistant infectionclinical developmentcombatdrug developmentdrug discoverydrug resistant bacteriadrug resistant pathogeneffective therapyfungusin vivoindustry partnerinnovationinsightmarinemetabolomicsmicrobialmicrobiomemulti-drug resistant pathogenmultidisciplinarynatural antimicrobialnext generationnovelnovel therapeuticspathogenpathogenic bacteriapathogenic funguspre-clinicalpreclinical studyscaffoldsecondary metabolitesmall moleculesuccesssymbionttheories
项目摘要
Project Summary
The discovery of new antimicrobials has failed to keep pace with the emergence of antimicrobial-resistant
infections, threatening public health. The overarching goal of the Wisconsin Antimicrobial Drug Discovery and
Development Center is to develop therapeutic countermeasures to tackle the antimicrobial resistance crisis.
Based upon our preliminary investigations using interdisciplinary, cutting-edge approaches, we hypothesize that
natural products from animal-microbe symbioses represent a new paradigm in antimicrobial drug discovery. The
Center proposes innovative conceptual and technical advances to overcome the critical bottlenecks of traditional
antimicrobial discovery to deliver therapeutic countermeasures for the drug-resistance epidemic.
Relevance
There is an ever-present and growing need to find novel, effective therapies for emerging resistant pathogens
that are becoming an increasing threat to the public health. The goals of the Center are to discover new
antimicrobial drugs. Our collaborative effort focuses on high-value natural products produced by under-
explored sources of biological and chemical diversity.
项目摘要
新的抗菌药物的发现未能跟上耐药性的出现。
感染,威胁公共卫生。威斯康星州抗菌药物发现和
发展中心的任务是制定治疗对策,以应对抗菌素耐药性危机。
基于我们使用跨学科、尖端方法的初步调查,我们假设,
来自动物-微生物共生体的天然产物代表了抗微生物药物发现的新范例。的
中心提出创新的概念和技术进步,以克服传统的关键瓶颈,
抗菌剂的发现,以提供耐药性流行病的治疗对策。
相关性
对于新出现的耐药病原体,寻找新的有效疗法的需求一直存在且不断增长
对公众健康的威胁越来越大该中心的目标是发现新的
抗微生物药物我们的合作重点是高价值的天然产品生产的下,
探索生物和化学多样性的来源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David R Andes其他文献
David R Andes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David R Andes', 18)}}的其他基金
Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi
基于共生的涡轮霉素的发现,这是一种针对耐药真菌的安全且选择性的抗真菌药物
- 批准号:
10584574 - 财政年份:2022
- 资助金额:
$ 595.5万 - 项目类别:
Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi
基于共生的涡轮霉素的发现,这是一种针对耐药真菌的安全且选择性的抗真菌药物
- 批准号:
10414553 - 财政年份:2022
- 资助金额:
$ 595.5万 - 项目类别:
Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course
分子真菌学:真菌发病机制的最新方法 (MoMy) 培训课程
- 批准号:
10461947 - 财政年份:2021
- 资助金额:
$ 595.5万 - 项目类别:
Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course
分子真菌学:真菌发病机制的最新方法 (MoMy) 培训课程
- 批准号:
10313447 - 财政年份:2021
- 资助金额:
$ 595.5万 - 项目类别:
Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course
分子真菌学:真菌发病机制的最新方法 (MoMy) 培训课程
- 批准号:
10664997 - 财政年份:2021
- 资助金额:
$ 595.5万 - 项目类别:
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
针对动物微生物共生体中的耐多药病原体的新型抗菌药物
- 批准号:
10376275 - 财政年份:2019
- 资助金额:
$ 595.5万 - 项目类别:
相似海外基金
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10590611 - 财政年份:2022
- 资助金额:
$ 595.5万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
- 批准号:
10706006 - 财政年份:2022
- 资助金额:
$ 595.5万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10368975 - 财政年份:2021
- 资助金额:
$ 595.5万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10365254 - 财政年份:2021
- 资助金额:
$ 595.5万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10202896 - 财政年份:2021
- 资助金额:
$ 595.5万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10531570 - 财政年份:2021
- 资助金额:
$ 595.5万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10541847 - 财政年份:2019
- 资助金额:
$ 595.5万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10319573 - 财政年份:2019
- 资助金额:
$ 595.5万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10062790 - 财政年份:2019
- 资助金额:
$ 595.5万 - 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
- 批准号:
DE170100628 - 财政年份:2017
- 资助金额:
$ 595.5万 - 项目类别:
Discovery Early Career Researcher Award